BIOCRYST PHARMACEUTICALS, INC.: cashflow_financing

Value{"amount": -1740000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2024-01-01 – 2024-09-30
Statuscurrent
EntityBIOCRYST PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001628280-24-045364
Retrieved: 2026-08-19T08:48:50.529413+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000882796/cashflow-financing/2024-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/2d68173f-03b0-4784-9250-2a5a245b8081

History